Gluten induced diseases

Czech version

Authors: P. Frič; M. Zavoral; T. Dvořáková
Authors‘ workplace: Interní klinika 1. lékařské fakulty UK a ÚVN – Vojenské fakultní nemocnice Praha, přednosta prof. MU Dr. Miroslav Zavoral, Ph. D.
Published in: Vnitř Lék 2013; 59(5): 376-382
Category: Review

Overview

The introduction of cereals in human nutrition 10 000 years ago caused the occurrence of gluten induced diseases. This protein complex is involved in pathogenesis of wheat allergy, celiac disease, and gluten sensitivity. Wheat allergy and celiac disease are mediated by the system of adaptive immunity. Gluten sensitivity is a recently defined entity induced by innate immune mechanisms. These subjects present various intestinal and particularly extraintestinal symptoms. The differences between celiac disease and gluten intolerance include permeability of the intestinal mucosal barrier, histology of duodenal biopsy, and mucosal gene expression. The symptoms of gluten sensitivity may also have another genetic background of food intolerance independent of the HLA‑DQ2, - DQ8 system and tissue transglutaminase (eg. in some psychiatric disorders). At present, there is no specific biomarker of gluten sensitivity. The diagnosis is possible only by exclusion of other causes of symptoms and improvement on a gluten‑free diet applied in a double‑blind placebo controlled manner with optional sequence of both stages to exclude the placebo effect due to nutritional intervention.

Key words:
gluten – wheat allergy – celiac disease – gluten sensitivity – innate and adaptive immunity

Sources

1. Tatham AS, Shewry PR. Allergens in wheat and related cereals. Clin Exp Allergy 2008; 38: 1712– 1726.

2. Fasano A. Zonulin and its regulation of intestinal barrier‑ function: The biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011; 91: 151– 175.

3. Fasano A. Zonulin, regulation of tight junctions and autoimmune disorders. Ann NY Acad Sci 2012; 1258: 25– 33.

4. Walker‑ Smith JA, Guandalini S, Schmitz JK et al. Revised criteria for diagnosis of celiac disease. Arch Dis Childhood 1990; 60: 909– 911.

5. Barrer CC, Milton C, Jevon G et al. Can tissue transglutamináze titers replace small‑bowel biopsy to diagnose celiac disease in selected pediatric populations? Pediatrics 2005: 115: 1341– 1346.

6. Donaldson MR, Firth SD, Wimpee H et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol 2007; 5: 567– 573.

7. Donaldson MR, Book LS, Lieferman KM et al. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 2008; 42: 256– 260.

8. Vivas S, De Morales JGR, Riestra S et al. Duodenal biopsy may be avoided when high transglutamináze antibody levels are present. World J Gastroenterol 2009; 15: 4775– 4780.

9. Hayat M, Cairns A, Dixon MF et al. Quantification of intraepithelial lymphocytes in human duodenum: what is normal? J Clin Pathol 2002; 55: 393– 395.

10. Dickson BC, Streutker CJ, Chetty R. Celiac disease: an update for pathologists. J Clin Pathol 2006; 59: 1008– 1016.

11. Scalon SA, Murray JA. Update on celiac disease – etiology, diagnosis, drug targets, and management advances. Clin Exp Gastroenterol 2011; 4: 297– 311.

12. Goldstein NS, Underhill J. Morphologic features suggestive of gluten sensitivity in architecturally normal duodenal biopsy specimens. J Clin Pathol 2001; 116: 69– 71.

13. Jarvinen TT, Collin P, Rasmussen M et al. Villous tip intraepithelial lymphocytes as markers of early stage celiac disease. Scand J Gastroenterol 2004; 39: 428– 433.

14. Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 2010; 56: 661– 665.

15. Sapone A, Lammers KM, Mazzarella G et al. Differential mucosal IL‑17 expression in two gliadin induced disorders: Gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol 2010; 152: 75– 80.

16. Sapone A, Lammers KM, Casolaro V et al. Divergence of gut permeability and mucosal immune gene expression in two gluten‑associated conditions: celiac disease and gluten sensitivity. BMC Medicíne 2011; 9: 23.

17. Sapone A, Bai JC, Ciacci C et al. Spectrum of gluten‑related disorders: consensus on new nomenclature and classification. BMC Medicine 2012; 10: 13.

18. Volta U, Tovoli F, Cicola R et al. Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol 2012; 46: 680– 685.

19. Junker Y, Zeissig S, Kim SJ et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll‑like receptor 4. J Exp Med 2012; 209: 2395– 2408.

20. Carroccio A, Mansueto P, Iacono G et al. Non‑ celiac wheat sensitivity diagnosed by double‑blind placebo‑ controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012; 107: 1898– 1906.

21. Sanders DS, Aziz I. Non‑ celiac wheat sensitivity: separating the wheat from the chat! Am J Gastroenterol 2012; 107: 1908– 1912.

22. Massari S, Liso M, De Santis L et al. Occurrence of nonceliac gluten sensitivity in patients with allergic disease. Int Arch Allergy Immunol 2011; 155: 389– 394.

23. Brottveit M, Vandvik PO, Wojniusz S et al. Absence of somatization in non‑celiac gluten sensitivity. Scand J Gastroenterol 2012; 47: 770– 777.

24. Bender L. Childhood schizophrenia. Psychiatric Quarterly 1953; 27: 663– 681.

25. Dohan, FC, Martin L, Grasberger JC et al. Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biol Psychiatry 1972: 12: 127– 137.

26. Samaroo D, Dickerson F, Kasarda DD et al. Novel immune response to gluten in individuals with schizophrenia. Schizophr Res 2010; 118: 248– 255.

27. Severance EG, Alaedini A, Yang S et al. Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res 2012; 138: 48– 53.

28. Dickerson F, Stallings C, Origoni A et al. Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord 2011; 13: 52– 58.

29. Dickerson F, Stallings C, Origoni A et al. Markers of gluten sensitivity in acute mania: a longitudinal study. Psychiatry Res 2012; 196: 68– 71.

30. Cooper BT, Holme GK, Ferguson R et al. Gluten‑ sensitive diarrhoea without evidence of celiac disease. Gastroenterology 1980; 79: 801– 806.

31. Ferguson A, Arranz E, O’Mahony S. Clinical and pathological spectrum of celiac disease – active, silent, latent, potential. Gut 1993; 34: 150– 151.

32. Kaukinen K, Mäki M, Partanen J et al. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci 2001; 46: 879– 887.

33. Wahnschaffe U, Ulrich R, Riecken E et al. Celiac disease‑like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001; 121: 1329– 1338.

34. Vande Voort JL, Murray JA, Lahr BD et al. Lymphocytic duodenosis and the spectrum of celiac disease Am J Gastroenterol 2009; 104: 142– 148.

35. Kakar S, Nehra V, Murray JA et al. Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol 2003; 98: 2027– 2033.

36. Black KE, Murray JA, David CS. HLA‑DQ2 determinates the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol 2006; 169: 5595– 5560.

37. Verdu EF, Huang XX, Natividad J. Gliadin‑dependent neuromuscular and epithelial secretory response in the gut. Am J Physiol Gastrointest Liver Physiol 2008; 294: G217– G225.

38. Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: „No man’s land“ of gluten sensitivity. Am J Gastroenterol 2009; 104: 1587– 1594.

39. Sirén M, Barbara G, Flint HJ et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159– 176.

40. Laparra JM, Sanz Y. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem 2010; 109: 601– 607.

41. D’Arienzo R, Maurano F, Lavermicocca P et al. Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity. Cytokine 2009; 48: 254– 259.

42. Pannini C, Saeed R, Bamias G et al. Probiotics promote gut health through stimulation of epithelial innate immunity. PNAS 2010; 107: 454– 459.

43. Ahn R, Ding YC, Murray J et al. Association analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci. PLoS One 2012; 7: e36926.

44. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008; 14: 1585– 1596.